Pliant Therapeutics (PLRX) Prepaid Assets (2019 - 2026)
Pliant Therapeutics (PLRX) reported Prepaid Assets of $3.1 million for Q1 2026, down 43.53% year-over-year from $5.5 million in Q1 2025, and down 29.84% quarter-over-quarter from $4.5 million in Q4 2025.
Pliant Therapeutics (PLRX) Prepaid Assets (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Prepaid Assets data on file, last reported at $3.1 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.1 million, down 43.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (down 43.53% YoY), and the FY2025 annual result was $4.5 million, down 31.74% from the prior year.
- Prepaid Assets retreated to $3.1 million in Q1 2026 per PLRX's latest filing, from $4.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $11.3 million in Q4 2023 and troughed at $3.1 million in Q1 2026.
- A 5-year average of $6.6 million and a median of $5.8 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets jumped 155.83% in 2023, then plunged 58.24% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $7.1 million in 2022, then jumped by 59.49% to $11.3 million in 2023, then sank by 41.9% to $6.5 million in 2024, then tumbled by 31.74% to $4.5 million in 2025, then declined by 29.84% to $3.1 million in 2026.
- Business Quant data shows PLRX's Prepaid Assets at $3.1 million in Q1 2026, $4.5 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 4.46 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 10.95 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 10.64 Mn |
| Jun 30, 2023 | 8.89 Mn |
| Mar 31, 2023 | 7.53 Mn |
| Dec 31, 2022 | 7.06 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.86 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 5.85 Mn |
| Jun 30, 2021 | 4.83 Mn |